Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein (HSIC) delivers essential healthcare products and services to dental, medical, and animal health practices worldwide. This news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives.
Track all official announcements through our curated collection of press releases and verified news coverage. Stay informed about earnings reports, product launches, partnership agreements, and operational milestones that shape Henry Schein's position in global healthcare distribution.
Key updates include acquisitions expanding service capabilities, technological innovations in supply chain management, and regulatory developments affecting medical device distribution. Our repository eliminates fragmented research by consolidating critical information from multiple sources.
Bookmark this page for efficient monitoring of HSIC's market activities. Return regularly to access new filings, leadership updates, and analysis of trends impacting healthcare providers and distributors.
Henry Schein Medical has announced the availability of Ansell Healthcare's AlphaTec® Model 214 gowns in North America. These non-surgical isolation gowns are made from DuPont™ Tyvek® 1222A fabric, providing superior chemical protection for front-line healthcare workers amid COVID-19. The partnership aims to enhance the accessibility of personal protective equipment (PPE) for healthcare institutions. The gowns feature advanced barrier protection and are available in two sizes, helping fulfill the increasing demand for reliable PPE in the healthcare sector.
Henry Schein Medical has partnered with Yosi Health to enhance patient experiences and streamline administrative processes through Yosi Intake, a digital patient scheduling and registration solution. This collaboration aims to create contactless waiting room experiences, increasing efficiency for healthcare practices. The partnership expands Henry Schein's SolutionsHub, providing a comprehensive suite of customizable solutions that meet the needs of various medical practices and facilities. This partnership is positioned to modernize patient visits while reducing costs and improving overall care quality.
Henry Schein, Inc. (Nasdaq: HSIC) commemorates its 25th anniversary as a public company by opening the Nasdaq Stock Market. The company raised $72.8 million during its IPO in 1995, and has since expanded significantly, achieving $10 billion in sales from continuing operations by 2019. With a market capitalization around $10 billion and over 19,000 employees serving more than one million customers globally, Henry Schein ranks on FORTUNE® magazine’s lists of the World’s Most Admired Companies and the World’s Most Ethical Companies.
Henry Schein (Nasdaq: HSIC) announces participation in the virtual Greater New York Dental Meeting (GNYDM) from November 27 to December 2. The company's virtual booths will showcase 3D imaging, printing, CAD/CAM solutions, and teledentistry to support dental practices amid COVID-19. Key presentations include risk mitigation technologies and office design insights. Additionally, Henry Schein will feature interactive discussions with industry leaders on diagnostic testing and teledentistry. This event aims to provide dental professionals with innovative solutions to enhance practice efficiency and patient care.
Henry Schein, a leading provider of health care solutions, will present at three investor conferences in December 2020. The events include the Piper Sandler 32nd Annual Healthcare Conference on December 1 at 1:00 p.m. ET, Evercore ISI 3rd Annual HealthCONx Virtual Conference on December 2 at 10:30 a.m. ET, and Nasdaq 43rd Virtual Investor Conference on December 4 at 11:30 a.m. ET. These presentations can be accessed via live webcast on the company's website, with replays available afterward.
Henry Schein reported record financial results for Q3 2020, with net sales reaching $2.8 billion, a 13.2% increase from Q3 2019. GAAP net income from continuing operations was $141.7 million or $0.99 per diluted share, reflecting an increase from the previous year. Non-GAAP net income grew to $147.0 million, or $1.03 per diluted share. Strong sales growth was driven by PPE and COVID-19-related products. However, the company anticipates sales growth to moderate going forward. There remains uncertainty due to the pandemic, prompting the company to withhold future financial guidance.
Henry Schein announced an exclusive distribution agreement with Carrizo Dental to distribute Henry Schein-brand products in Argentina. This partnership enhances access to a variety of dental supplies for local practitioners, who previously had to import products from other markets. The agreement aims to streamline the purchasing process and improve clinical outcomes with local support and product training available. This collaboration reflects Henry Schein’s commitment to advancing local oral health care in Argentina.
Henry Schein, Inc. (Nasdaq: HSIC), a leader in health care solutions, has announced its participation in two virtual investor conferences in November 2020. The events include the Credit Suisse 29th Annual Virtual Healthcare Conference on November 10 at 2:00 pm ET, and the Wolfe Research Virtual Healthcare Conference on November 19 at 3:30 pm ET. Interested parties can access live webcasts of the presentations at www.henryschein.com/IRwebcasts, with replays available after the events.
Henry Schein (Nasdaq: HSIC) and The Dentists Supply Company (TDSC) have completed an agreement to form a new entity aimed at serving state dental association members through an online platform. Known as TDSC.com, this service will provide everyday low pricing for dental supplies. Henry Schein is the majority owner of TDSC, which had 2019 sales of approximately $20 million. The partnership is expected to be neutral to Henry Schein’s 2020 earnings per diluted share and accretive thereafter, enhancing their online order capabilities and product offerings.
Henry Schein (Nasdaq: HSIC) continues its commitment to cancer support through the Practice Pink® program, now in its 14th year, donating over $1.7 million towards cancer detection and care. The program collaborates with various nonprofits, including the American Cancer Society, and promotes awareness in the dental and medical fields by offering pink-themed products. CEO Stanley M. Bergman emphasizes the collective efforts to improve access to treatment and prevention. For further details on this initiative, visit www.henryschein.com/PracticePink.